Baseline and/or dynamic changes in plasma basic fibroblast growth factor , E-selectin , intercellular adhesion molecule-@ , placental growth factor , VEGFR-@ and VEGFR-@ , and tumor biomarkers did not correlate statistically with treatment outcomes for bevacizumab plus chemotherapy .